Rescue of Amyloid-Beta-Induced Inhibition of Nicotinic Acetylcholine Receptors by a Peptide Homologous to the Nicotine Binding Domain of the Alpha 7 Subtype

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Nery, Arthur A ^a   Magdesian, Margaret H ^b   Trujillo, Cleber A ^a   Sathler, Luciana B ^b   Juliano, Maria A ^c   Juliano, Luiz ^c   Ulrich, Henning ^a   Ferreira, Sergio T ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMYLOID BETA PROTEIN[1-40]; BUNGAROTOXIN RECEPTOR; CARBACHOL; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA3; NICOTINIC RECEPTOR ALPHA3BETA4; NICOTINIC RECEPTOR ALPHA5; NICOTINIC RECEPTOR BETA2; NICOTINIC RECEPTOR BETA4; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MUTAGENESIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; AMINO ACID SEQUENCE; AMYLOID BETA-PEPTIDES; ANIMALS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; NICOTINE; NICOTINIC ANTAGONISTS; OLIGOPEPTIDES; PC12 CELLS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RATS;

EID: 84880674798     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067194     Document Type: Article

References (63)

1. Alzheimer's Association (2010) Alzheimer's disease facts and figures. Alzheimers Dement 6: 158-194.
2. Ferreira ST, Klein WL, (2011) The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease. Neurobiol Learn Mem 96: 529-543.
3. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, et al. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95: 6448-6453.
4. Riek R, (2006) Cell biology: infectious Alzheimer's disease? Nature 444: 429-431.
5. Greenwald J, Riek R, (2010) Biology of amyloid: structure, function, and regulation. Structure 18: 1244-1260.
6. Ferreira ST, Vieira MN, De Felice FG, (2007) Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases. IUBMB Life 59: 332-345.
7. Selkoe DJ, (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192: 106-113.
8. Nordberg A, (2001) Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol Psychiatry 49: 200-210.
9. Kadir A, Almkvist O, Wall A, Långström B, Nordberg A, (2006) PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease. Psychopharmacology (Berl) 188: 509-520.
10. Lindstrom JM, (2003) Nicotinic acetylcholine receptors of muscles and nerves: comparison of their structures, functional roles, and vulnerability to pathology. Ann N Y Acad Sci 998: 41-52.
11. Clementi F, Fornasari D, Gotti C, (2000) Neuronal nicotinic receptors, important new players in brain function. Eur J Pharmacol 393: 3-10.
12. Small DH, Maksel D, Kerr ML, Ng J, Hou X, et al. (2007) The beta-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the α7 nicotinic acetylcholine receptor,. J Neurochem 101: 1527-1538.
13. Wang HY, Lee DH, D'Andrea MR, Peterson PA, Shank RP, et al. (2000) Beta-Amyloid (1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem 25: 5626-5632.
14. Wang HY, Lee DH, Davis CB, Shank RP, (2000) Amyloid peptide Aβ1-42 binds selectively and with picomolar affinity to α7 nicotinic acetylcholine receptors. J Neurochem 75: 1155-1161.
15. Nagele RG, D'Andrea MR, Anderson WJ, Wang HY, (2002) Intracellular accumulation of beta-amyloid (1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neurosci 110: 199-211.
16. Wang HY, Bakshi K, Shen C, Frankfurt M, Trocmé-Thibierge C, et al. (2010) S 24795 limits beta-amyloid-alpha7 nicotinic receptor interaction and reduces Alzheimer's disease-like pathologies. Biol. Psychiatry 67: 522-530.
17. Dineley KT, (2007) Beta-amyloid peptide-nicotinic acetylcholine receptor interaction: the two faces of health and disease. Front Biosci 12: 5030-5038.
18. Jürgensen S, Ferreira ST, (2010) Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer's disease. J Mol Neurosci 40: 221-229.
19. Pettit DL, Shao Z, Yakel JL, (2001) Beta-Amyloid1-42 peptide directly modulates nicotinic receptors in the rat hippocampal slice. J Neurosci 21: RC120.
20. Liu QS, Kawai H, Berg DK, (2001) Beta-amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons. Proc Natl Acad Sci USA 98: 4734-9.
21. Grassi F, Palma E, Tonini R, Amici M, Ballivet V, et al. (2003) Amyloid beta (1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors. J Physiol 547: 147-157.
22. Wu J, Kuo YP, George AA, Xu L, Hu J, et al. (2004) beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells. J Biol Chem 279: 37842-37851.
23. Pym L, Kemp M, Raymond-Delpech V, Buckingham S, Boyd CA, et al. (2005) Subtype-specific actions of beta-amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (a7, a4b2, b3b4) expressed in Xenopus laevis oocytes,. Br J Pharmacol 146: 964-971.
24. Magdesian MH, Nery AA, Martins AH, Juliano MA, Juliano L, et al. (2005) Peptide blockers of the inhibition of neuronal nicotinic acetylcholine receptors by amyloid beta. J Biol Chem 280: 31085-31090.
25. Fu W, Jhamandas JH, (2003) Beta-amyloid peptide activates non-alpha7 nicotinic acetylcholine receptors in rat basal forebrain neurons. J Neurophysiol 90: 3130-3136.
26. Lamb PW, Melton MA, Yakel JL, (2005) Inhibition of neuronal nicotinic acetylcholine receptor channels expressed in Xenopus oocytes by betaamyloid1-42 peptide. J Mol Neurosci 27: 13-21.
27. Dineley KT, Bell KA, Bui D, Sweatt JD, (2002) Beta-Amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Biol Chem 277: 25056-25061.
28. Dougherty JJ, Wu J, Nichols RA, (2003) Beta-amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex. J Neurosci 23: 6740-6747.
29. Wu J, Khan GM, Nichols RA, (2007) Dopamine release in prefrontal cortex in response to beta-amyloid activation of alpha7 nicotinic receptors. Brain Res 1182: 82-89.
30. Puzzo D, Privitera L, Leznik E, Fà M, Staniszewski A, et al. (2008) Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28: 14537-14545.
31. Buckingham SD, Jones AK, Brown LA, Sattelle DB, (2009) Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection. Pharmacol Rev 61: 39-61.
32. Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J, et al. (2001) Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411: 269-276.
33. Udgaonkar JB, Hess GP, (1987) Chemical kinetic measurements of a mammalian acetylcholine receptor by a fast-reaction technique. Proc Natl Acad Sci U S A 84: 8758-8762.
34. Ulrich H, Ippolito JE, Pagán OR, Eterović VA, Hann RM, et al. (1998) In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A 95: 14051-14056.
35. Ulrich H, Akk G, Nery AA, Trujillo CA, Rodriguez AD, et al. (2008) Mode of cembranoid action on embryonic muscle acetylcholine receptor. J Neurosci Res 86: 93-107.
36. Nery AA, Resende RR, Martins AH, Trujillo CA, Eterovic VA, et al. (2010) Alpha 7 nicotinic acetylcholine receptor expression and activity during neuronal differentiation of PC12 pheochromocytoma cells. J Mol Neurosci 4: 329-339.
37. Williams DK, Stokes C, Horenstein NA, Papke RL, (2009) Differential regulation of receptor activation and agonist selectivity by highly conserved tryptophans in the nicotinic acetylcholine receptor binding site. J Pharmacol Exp Ther 330: 40-53.
38. Chiara DC, Cohen JB, (1997) Identification of amino acids contributing to high and low affinity d-tubocurarine sites in the Torpedo nicotinic acetylcholine receptor. J Biol Chem 272: 32940-32950.
39. Corringer PJ, Galzi JL, Eisele JL, Bertrand S, Changeux JP, et al. (1995) Identification of a new component of the agonist binding site of the nicotinic alpha 7 homooligomeric receptor. J Biol Chem 270: 11749-11752.
40. Cheffer A, Mustafá EV, T-do Amaral A, Ulrich H, (2012) Lipophilicity as a determinant of binding of procaine analogs to rat α3β4 nicotinic acetylcholine receptor. J Neurosci Res 90: 1607-1614.
41. Moaddel R, Jozwiak K, Yamaguchi R, Cobello C, Whittington K, et al. (2004) On-line screening of conformationally constrained nicotines and anabasines for agonist activity at the alpha3beta4- and alpha4beta2-nicotinic acetylcholine receptors using immobilized receptor-based liquid chromatographic stationary phases. J Chromatogr B Analyt Technol Biomed Life Sci 813: 235-240.
42. Cheffer A, Ulrich H, (2011) Inhibition mechanism of rat α3β4 nicotinic acetylcholine receptor by the Alzheimer therapeutic tacrine. Biochemistry 50: 763-770.
43. Nunes-Alves A, Nery AA, Ulrich H, (2013) Tobacco nitrosamine N-nitrosonornicotine as inhibitor of neuronal nicotinic acetylcholine receptors. J Mol Neurosci 49: 52-61.
44. Azam L, McIntosh JM, (2009) Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors. Acta Pharmacol Sin 30: 771-783.
45. Salas R, Cook KD, Bassetto L, De Biasi M, (2004) The alpha3 and beta4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice. Neuropharmacology 47: 401-417.
46. Mehta PD, Pirttila T, Patrick BA, Barshatzky M, Mehta SP, (2001) Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease. Neurosci Lett 304: 102-106.
47. Zappettini S, Grilli M, Olivero G, Mura E, Preda S, et al. (2012) Beta amyloid differently modulate nicotinic and muscarinic receptor subtypes which stimulate in vitro and in vivo the release of Glycine in the rat hippocampus. Front Pharmacol 3: 146.
48. Mura E, Zappettini S, Preda S, Biundo F, Lanni C, et al. (2012) Dual effect of beta-amyloid on α7 and α4β2 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hippocampus. PLoS One 2012;7 (1) (): e29661.
49. Corringer PJ, LeNoveÁre N, Changeux JP, (2000) Nicotinic receptors at the amino-acid level. Annu Rev Pharmacol Toxicol 40: 431-458.
50. Arias HR, (2000) Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors. Neurochem Int 36: 595-645.
51. Dennis M, Giraudat J, Kotzyba-Hibert F, Goeldner M, Hirth C, et al. (1988) Amino acids of the Torpedo marmorata acetylcholine receptor alpha subunit labeled by a photoaffinity ligand for the acetylcholine binding site. Biochemistry 27: 2346-2357.
52. Galzi JL, Revah F, Black D, Goeldner M, Hirth C, et al. (1990) Identification of a novel amino acid alpha-tyrosine 93 within the cholinergic ligand binding sites of the acetylcholine receptor by photoaffinity labeling. Additional evidence for a three loop model of the cholinergic ligands-binding sites. J Biol Chem 265: 10430-10437.
53. Fu DX, Sine SM, (1994) Competitive antagonists bridge the alpha-gamma subunit interface of the acetylcholine receptor through quaternary ammonium-aromatic interactions. J Biol Chem 269: 26152-26157.
54. D'Andrea MR, Nagele RG, (2006) Targeting the alpha7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons. Curr Pharm Des 12: 677-684.
55. Martin-Ruiz CM, Court JA, Molnar E, Lee M, Gotti C, et al. (1999) Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J Neurochem 73: 1635-1640.
56. Gotti C, Moretti M, Bohr I, Ziabreva I, Vailati S, et al. (2006) Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation. Neurobiol Dis 23: 481-489.
57. Dziewczapolski G, Glogowski CM, Masliah E, Heinemann SF, (2009) Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease. J Neurosci 29: 8805-8815.
58. Tayeb HO, Murray ED, Price BH, Tarazi FI, (2013) Bapineuzumab and solanezumab for Alzheimer's disease: is the 'amyloid cascade hypothesis' still alive? Expert Opin Biol Ther 2013 Apr 10. [Epub ahead of print].
59. Ho PL, Raw I, (1992) Cyclic AMP potentiates bFGF-induced neurite outgrowth in PC12 cells. J Cell Physiol 150: 647-656.
60. Xiao Y, Meyer EL, Thompson JM, Surin A, Wroblewski J, et al. (1998) Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function. Mol Pharmacol 54: 322-333.
61. Krivoshein AV, Hess GP, (2004) Mechanism-based approach to the successful prevention of cocaine inhibition of the neuronal (alpha 3 beta 4) nicotinic acetylcholine receptor. Biochemistry 43: 481-489.
62. Niu L, Abood LG, Hess GP, (1995) Cocaine: mechanism of inhibition of a muscle acetylcholine receptor studied by a laser-pulse photolysis technique. Proc Natl Acad Sci U S A 92: 12008-12012.
63. Hess GP, Ulrich H, Breitinger HG, Niu L, Gameiro AM, et al. (2000) Mechanism-based discovery of ligands that counteract inhibition of the nicotinic acetylcholine receptor by cocaine and MK-801. Proc Natl Acad Sci U S A 97: 13895-13900.